What is the size of the global minimally invasive surgery (MIS) market?

The market for minimally invasive surgery (MIS) was estimated to be worth USD 60 billion in 2023 and is expected to increase to USD 116.92 billion by 2030, with a projected compound annual growth rate (CAGR) of 10% from 2024 to 2030.

What are the primary drivers of the global minimally invasive surgery (MIS) market?

The primary drivers of the global minimally invasive surgery (MIS) market include the increasing prevalence of chronic diseases, advancements in surgical technologies, and growing demand for shorter hospital stays and quicker recovery times.

What are the key challenges facing the global minimally invasive surgery (MIS) market?

The key challenges facing the global minimally invasive surgery (MIS) market include the high cost of equipment, limited access to advanced technology in certain regions, and the learning curve associated with adopting new surgical techniques.

Which region entirely dominates the global minimally invasive surgery (MIS) market?

In 2023, North America held the largest share of the global minimally invasive surgery (MIS) market.

What are the key players in the global minimally invasive surgery (MIS) market?

Medtronic plc, Johnson & Johnson (Ethicon, Inc.), Stryker Corporation, Intuitive Surgical, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Smith & Nephew plc, Abbott Laboratories, Karl Storz GmbH & Co. KG, Zimmer Biomet Holdings, Inc., and Applied Medical Resources Corporation are the main players.